NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Kinnos

Kinnos

Private
Brooklyn, New YorkHealthcare & Life Scienceshttps://www.kinnos.com

Last Round

Early Funding

May 2, 2023

Total Funding Raised

$15M

Momentum

Quiet

No recent growth signals

Company Overview

Kinnos is an infection prevention company that develops and manufactures Highlight®, a patented color additive platform for disinfectants. Founded in 2014 in response to the Ebola outbreak, the company's technology temporarily colorizes disinfectants to provide a visual cue, ensuring complete surface coverage and improving cleaning compliance. This addresses human error during disinfection, which contributes to healthcare-associated infections (HAIs). Kinnos markets its products to hospitals, first responders, and transit agencies to create safer environments. The company is venture-backed and has raised significant capital to support its growth and product development.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Facility Management, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

color additive platform for disinfectantstemporary color additive for disinfectantspatented disinfectant colorization technologysurface disinfection visualization tooldisinfectant coverage verificationhealthcare-associated infection (HAI) prevention tooldisinfectant wipe color additive systemenvironmental services (EVS) cleaning toolreal-time disinfection training toolinfection prevention technologydisposable color cartridges for disinfectantsfirst responder decontamination equipmentliquid bleach powder additive

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinnos Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kinnos Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 2, 2023

Kinnos Investors

Notable investors and investment history

InvestorRounds
Partnership for New York CityEarly Funding
The New York City Investment FundEarly Funding
Kapor CenterEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2025

    Product 'Highlight' recognized in Fierce Life Sciences’ Innovation Awards.

  • Apr 1, 2025

    Product 'Highlight' received Fast Company's Innovation by Design Award.

Kinnos Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kinnos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kinnos's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range9
Year Founded2014
Last FundingMay 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.